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                INTRODUCTION
Chyluria is the presence of chyle in the urine.  This has been recognized 
since the time of Charak (300 BC) who described it as 'Shuklameha'
Hippocrates recognized and described chyluria (1, 2). Following discovery 
of the lymphatic circulation by JEAN Pecquet in  1651, Moellenbrogii (13) 
ascribed chylous urine to an abnormal junction of the lymphatic  and urinary 
systems. Nearly 100 years later Otto Wucherer, working in Brazil in 1866, 
found microfilaria in the urine of a patient with heamaturia. Wood in 1929 
\first demonstrated pyelolymphatic backflow in retrograde pyelography. 
KITTREDGE and Associates and others utilized lymphangiography to 
demonstrated the  anatomic involvement seen in this  condition.
It is not uncommon in the Asia especially in India, Japan, Hong Kong and 
Tai wan.  It is rare in western countries. (4.11). It is believed to occur as a 
result of communication  between the lymphatics and the renal collecting 
system. (3, 5, 6, 11) Al though not life threatening in most cases, it can be 
disturbing and sometimes debilitating if the chyle loss in  urine is profuse. 
The disease is largely the chronic stage of filarial disease and is therefore  
an endemic disease.(7) Management includes conservative measures like 
avoidance of fat,  anti filarial drugs etc; minimally invasive techniques like 
renal pelvic instillation  of  sclerosing agents and invasive procedures like 
renal decapsulation,  retroperitoneoscopic  nephrolympholysis etc. 
Instillation of 1% silver nitrate into the renal pelvis has been the initial 
treatment modality if conservative measures failed. However, this procedure 
may be associated with serious complications like acute renal  failure (8), 
life threatening hemorrhage  (9) and death (10). 
Povidone iodine as a sclerosing agent has been shown to be effective and 
safe in the  management of chyluria. Herein, we present our experience of 
treating  chyluria with  povidone iodine  instillation in to the renal pelvis in 
the Department of Urology Stanley Medical College, Chennai, Tamilnadu, 
India. 
                                 
2. REVIEW OF LITERATURE
Chyluria is believed to arise largely from parasitic infestation, especially 
Wuchereria bancrofti. Other non-parasitic causes such as malignant tumors 
of thoracic duct, trauma or  pregnancy were occasionally seen. (44)
The parasitic infestation causes inflammation of the retroperitoneal 
lymphatics and therefore leads to obstruction,  tortuous, dilatation and 
subsequent rupturing into  pyelocaliceal system. 
The level of communication between the lymphatics and pyelocaliceal 
system can be any where in the urinary tract, but  it occurs most commonly 
in the renal pelvis.(45) The presentations are imperatively composed of
milky white urine passage, in association with dysuria,
hematuria, loss of protein and fat causing hypoproteinemia, weight loss, 
malnutrition and cachexia. 
Classification of chyluria
Etiologically, chyluria has been classified into parasitic and nonparasitic 
forms:  
1.Parasitic (primary-tropical)
Wuchereriabancrofti 
Eustrongylusgigas 
Taeniaechinococcus 
Taenianana 
Malarialparasites 
Cereonomas hominis.
2. Nonparasitic(secondary:nontropical)
Congenital
Lymphangiomas of urinary tract
Megalymphatics with urethrvesicle  fistula
Stenosis of thoracic duct
Retroperitoneal lympheangectasia
Traumatic lymphangio urinary fistula
Lymphatic  obstruction due to tumor
Obstruction of deep retrperitonal lymphatics by other causes.
Pregnancy;
Diabetes;
Perniceous anaemia
Parasitic chyluria
 A numbers of parasites besides Wuchereria bancrofti have been 
incriminated by various workers as a cause of chyluria eg. Eustrongylus 
gigas, Taenia echinococcus, and malarial parasite. Taenia nana, Ascaris, S. 
Haematobium, and Ceronomas hominis . It is not clear, however, as to 
whether these parasites are actually responsible or whether their presence 
is merely coincidental. By far the most important and the most common 
cause-effect relationship of chyluria is with Wuchereria bancrofti. The 
endemic occurrence of chyluria in filaria infested regions and demonstration 
of parasites in the blood, lymph or urine of chyluric individuals by various 
workers supports this view.(79) 
Patrick Manson, known internationally as "the father of tropical medicine", 
while working in the remote Chinese port city of Amoy in 1877, first 
identified that mosquitoes were responsible for the transmission of 
lymphatic filariasis. Following the introduction in 1947 of the drug 
diethylcarbamazine (DEC) for the treatment of the disease, a number of 
countries (Japan, China, Malaysia, Korea and some islands in the Pacific) 
made significant improvement in treatment of lymphatic filariasis.In 1993, 
an independent International Task Force for Disease Eradication identified 
LF as one of only six eliminable infectious diseases. Lymphatic filariasis  
was selected because of advances in treatment methods, both for controlling 
transmission and for managing the disease. (87) 
The World Health Assembly (1997) adopted a resolution calling for the 
elimination of  lymphatic filariasis  as a public health problem worldwide. 
The principal strategy for interrupting transmission of infection is to identify 
areas in which  lymphatic filariasis  is endemic and then implement 
community-wide programmes to treat the entire at-risk population. The goal 
of such treatment is to break the cycle of transmission between mosquitoes 
and humans. 
There are six pathogenic nematodes (round worm) belonging to superfamily 
filariodea which develop to adult stage in humans .The adult female W. 
bancrofti is a pale, threadlike nematode measuring 6-10 cm in length and 
0.2 mm in width . The male is smaller, at 4-6 cm in length and 0.1 mm 
width. Larvae (microfilarias) in the blood of human hosts are ingested when 
the insect vectors feed . Within the vector, the microfilarias migrate to 
specific sites and develop from first-stage larvae into infective third-stage 
larvae. The vector transmits the infective larvae into a human host when 
feeding. Mosquitoes deposit the larvae on the host skin adjacent to the 
puncture site and the third stage larval (L3) parasites migrate through the 
venous system and lungs to eventually reside in the lymphatics. 
                                                     In adolescent and adult men, there is a 
preference for the lymphatics of the spermatic cord. There they form nests 
occupied by male and female worms, and produce the first stage larvae or 
microfilariae by viviparous reproduction These larvae migrate from the 
lymphatics to the peripheral blood where mosquitoes ingest them. The 
developing microfilariae become third stage larva, L3, within the mosquito. 
Their lifespan of 5-10 years renders adult worms are more resistant to anti-
infective agents than are microfilariae. Microfilariae may live up to several 
months. The diurnal periodicity of microfilaria distribution in the blood 
stream is not related to discharge from the mature female, but instead relies 
on a circadian rhythm related to mosquito feeding patterns, which is not well 
understood.  
Nonparasitic chyluria
 
Nonparasitic conditions are rare causes of chyluria are usually associated 
with a process of stenosis or obstruction of the thoracic duct or 
retroperitoneal lymphatics.(80,81) The common causes are tuberculosis, 
reteroperitioneal abscess and neoplastic infiltration of retroperitional 
lymphatics, trauma and pregnancy. A case of chyluria has been reported 
following an aortoiliac bypass graft and another in a patient following 
percutaneous nephrolithotomy.
PATHOGENESIS
   CHYLURIA is an abnormal urinary condition in which intestinal chyle 
appears in the  urine as a result of fistulous communications between the 
lymphatic path ways  transmitting chyle) and the urinary tract at  or beyond 
the level of the renal tubules either  within the kidney, the renal pelvis or the 
urinary bladder.
LYMPHATICS OF THE KIDNEY
Fall into three groups.
1. Inter-Tubular lymphatics –within the substance of the kidney
2. Subcapsular lymphatics and
3. Perinephric lymphatics
Groups (2) and (3) communicate with each other and join the renal pelvic 
lymphatics to  drain into the superior mesenteric nodes. The inter tubular 
lymphatics, coursing along and around the renal vascular pedicle and 
through    the upper para-aortic nodes (viz) sup. Mesenteric and celiac nodes, 
terminate finally in the cisterna chyli .Many of the right renal lymphatics and 
a few from the left drain mainly into the descending  intercostals trunk  
which joins with the kidney drain mainly into the descending intercostal 
trunk which  joins with the cisterna chyli. 
The pelvic and para aortic lymphatic traverse the upper Para-aortic nodes 
draining into  the  cisterna chyli asright and left lumber trunks. The intestinal 
lymphatics carrying chyle  also course through these nodes to terminate in 
cisterna chyli as gastro intestinal trunk. It may thus be noted that the three 
tributaries of  the cisterna chyli(viz) the right left lumbar  trunks and the 
gastrointestinal trunk course  through the upper para-aortic nodes prior to 
their termination  into cisterna chyli and  these nodes also act as 
intermediary stations for  the renal and renal  pelvic  
lymphatics.Nonetheless, the renal lymphatics act as safety valves capable of 
balancing   extra fluid loads under conditions of overload, as in renal  pelvic 
or  ureteral obstruction  .In  addition,  intrarenal lymphatics play a role in  
maintaining a low  interstitial oncotic  presure,  allowing the urine to become  
concentrated from the  reabsorption of water and  solutes through  the 
lymphatic  pathway.
   Whenever there is a obstruction to the flow of chyle at the level of the 
upper para-aortic   nodes (as happens in Filarial Chyluria  due to fibrotic 
changes in the lymph nodes)- the  intestinal chyle being unable to course 
through these nodes takes a deviated retrograde  course along the renal and 
renal pelvic lymphatics which become engorged with chyle  and indue 
course the hydrostatic pressure in them increases to sufficient magnitude as 
to  cause rupture into the renal tubles or into the renal pelvis with resultant 
escape of  intestinal chyle into the urinary tract and its appearance in the 
urine. Kinmonth and associates have called attention to the fact that  chyluria 
may occur as a  part of the primary disease of the lymphatic system. 
(MEGALYMPHATICS or LYMPHATIC   deficiency).The focus of 
“Rupture” into or communication with the urinary tract may apparently 
occur at any level (that is, calyces, pelvis ureter or ladder)    
Pathophysiology
This has been explained by two theories
1. Obstructive theory
The parasitic infestation produces obliterative lymphangitis and lymphatic 
hypertension, which subsequently generate varicosity and collateral 
formation. Once lymphatics are dilated their valvular system fails adding to 
back flow and dilatation. This theory has been in vogue for nearly 100 years 
and appears partly contributory.
 
2. Regurgitative theory
 The toxins released from dying filarial worms leads to some kind of 
weakness in the lymphatic wall ('ectasia'), which in turn leads to impairment 
of valvular mechanism. Direct inflammatory damage of valves may cause 
additional effect. Thus, regurgitation of chyle from cisterna chyli or large 
lymphatic trunk into the other may lead to varicosity and subsequently 
chyluria by rupture of these varicosities/dilated lymphatics into renal calyces 
or pelvis. 
The route from the intestinal to the renal lymphatics has been the subject of 
much speculation but it is agreed that chyle must first travel from the lacteals 
to the cisterna chili or thoracic duct. Then because of obstruction and/or 
insufficiency of the valvular system of lymph channels there is a reterograde 
flow to the upper lumbar lymph glands, which drain the renal lymphatics. 
Definite inadequacy of the lymphatic vessel valves exist since retrograde 
flow is frequently seen extending down the prevertebral and paravertebral 
regions on reterograde pyelography. It has been clinically observed and 
experimentally demonstrated that congestion in the lymphatics resulting 
from inflammation produces varix of its afferent vessels. It is believed that 
chyluria occurs because of retroperitoneal lymphatics receiving lymph flow 
from the intestinal lymphatics become obstructed secondary to fibrosis 
produced by parasitic infestation thus short-circuiting chyle from the 
intestinal lacteals to renal lymphatics, which rupture subsequently.
CLINICAL FEATURES OF CHYLURIA
The onset of chyluria may be insidious or sudden (11), is characteristically 
intermittent ( 1, 11,18), and usually occurs  between the second and fifth 
decade of life  (11),  although it has been recorded in all age groups (1, 21) 
Chyluria may exist for years without materially compromising the health of 
the patient (1,11), No sex predominance  exists  (ORTIZ and associates). 
chyluria originating from the kidney may be unilateral or  Bilateral. 
Secondary   pyelonephritis develops in many patients. The only 
constant symptom is  passage of urine that is opaque, white and of milky 
consistency (1);  if blood is also present the urine may appear pink formation 
of fibrinous clot with its  irritative effect in the  genito-urinary tract accounts 
for the symptoms of backache,  urgency, frequency,  Dysuria, ureteric colic 
and rarely acute urinary  retention. 
Blood loss may lead to minimal or moderate iron deficiency anaemia 
(11) massive proteinuria may cause   HYPROTEINEMIA and reversal of 
the albumin/globulin ratio   (14). Loss of fat may lead to weight loss, which  
becomemanifest in the  subcutaneous tissues and account for the peculiar,  
anxious,wizened  facies so often seen in patients with CHYLURIA 
(11).Recurrences and  exacerbationshave been attributed to such factors as 
posture,   exercise,diet,menstruationand  pregnancy (11).   In the study of 
lymphatic Dynamics in Filarial chyluria by P.C.Rajaram and colleagues  AP  
Skiagrams of the kidney ureter Bladder area   and chest were taken 15, 30, 
minutes, 1 1/2, 3, 6, and 9 hours after completion of the  injection. The 
things were determined by the flow of contrast as assessed by fluoroscopy  
and by the first or second set of  lymphograms. Each  skiagram is studied for 
the  appearance of contrast in the bladder before the patient is asked to  
empty the bladder,  and he is instructed not to void urine till  the next x-ray 
is taken. If the contrast is demonstrated in the  bladder the patient is x- rayed 
also the next day Thereafter daily lymphograms are obtained. They have 
combined lymphography with excretory   urography and Tomography in a 
few cases. 
Follow through excretory urography in14   cases24 to 48 hour after 
lymphography has helped to assess renal function, to 
study the  calyceal pattern, to delineate the lymphatico-urinary fistulae in 
relationship with the calyces  and renal pelvis and to demonstrate 
pyelolymphatic reflux which is  evidenced by  recopacification of 
lymphographic contrast by excretory urographich  contrast in the renal  
lymphatic and adjacent para-aorticlymphatics and nodes.The outstanding 
finding in lymphangiography is a marked increase in the   number, size  and  
Caliber of pelvic and retroperitoneal lymphatic vessels.  The vessels become  
tortuous. 
Abnormal communication (URINARY LYMPHATIC FISTULA) with the 
urinary tract  may  e seen. These fistulas are large enough to allow 
opacification of the pelvicalyceal  system by lymphangiographic contras 
medium in 40-50% of cases. A massively dilated vermiform plexus of 
lymphatic vessels has been demonstrated in the pelvis running 
medially and anterior  from the iliac vessels towards the bladder     
            
 Most interesting is the demonstration of abnormal communications 
between the retroperitoneal  and renal lymph vessel. These dilated, tortuous 
vessels appear to follow the collecting  system and not infrequently a fine 
halo of  lymph  vessels can be seen surrounding the  minor ealyees . The 
Lumbar lymph nodes are poorly visualized. They may appear to be almost 
entirely absent throughout   the entire lilac and  para aorticchai, but several 
are  usually visualized and these are often  enlarged. 
It is though that lymph nodes fail to visualize because of obstruction,but  
KOELIER  and associates visualized it and found it normal in 13of their15 
cases.  Dramatic anatomic demonstration have resulted from combining 
excretory urography on retrograde with chyluria has accumulated (23, 24 ).
Investigations
Chylous urine is best studied immediately after it has been voided. A fatty 
diet a day or night before has been used to enhance chyluria. On gross 
inspection, classic chylous urine is like milk, frequently containing a 
semisolid gel. Blood and fibrin clots are frequently observed in most of the 
samples. When kept in the test tube, it usually settles down into three layers, 
the fat being lighter gets deposited as the top layer, the fibrin clots from the 
middle layer and cells together with debris settle in the bottom 
layer.(62,63,64) 
   
When equal part of the milky urine and ether are vigorously shaken for a 
few minutes, there is almost complete clearing of opacity with slight 
turbidity remaining in the lower nonether zone. Under the microscope the 
sediment is found to contain variable number of erythrocytes and 
lymphocytes. The latter when stained fresh with one or two drops of 1:1500 
aquous solution of methylene blue reveals small lymphocytes floating single 
or in clumps. Fat droplets of varying size can be seen. Casts and cylindroids 
are usually absent.(62,63) Chylomicrons can be seen directly under 
microscope with dark ground illumination or stained with Sudan III. Oral 
ingestion of fat labelled with Sudan III (10 gm of butter with 100 mg of 
Sudan red III) causes orange pink colouration of urine in chylurics with in 2-
6 h,(64) but Sudan III being expensive is not freely available. 
The urine examination at the hands of various pathologists has been found to 
inaccurate number of times, particularly if chyluria is mild. This is partly 
due to less sensitively of ether test where only subjective methods are 
employed to see the resolution of turbidity. 
Recently, focus is being shifted to biochemical as well as electrophoretic 
study to detect the lipid constituents of urine and recently urinary 
triglyceride have been demonstrated to be universally present even if the 
urine is clinically clear.(65) Whether chyluria is continuous/intermittent mild 
or severe, urinary triglycerides are invariably detected in morning samples. 
Patients of UTI or phosphaturia are negative for the same. Estimation of 
urinary triglycerides is 100% sensitive and specific test for chyluria. 
It is noninvasive and cost effective and is independent of manual error. The 
etimated values of chylomicrons, TGs and cholesterol in urine may point to 
the level of abnormal communication.
Similarly, urine albumin has been found in varying ranges from mild to 
nephrotic range(75) and immunoelectrophroresis has shown globulins of 
various types and apolipoprotein A 48 of intestinal origin in the urine. The 
urine may sometimes contain predominantly blood and sometimes, the 
severe haematochyluria in accompanied with a clot in bladder which is often 
confused as carcinoma bladder. 
Localization of lympho-urinary fistulae
Urologic investigations to localise site of lymphatico-urinary fistulae and 
obstruction should include, cystourethroscopy, retrograde pyelography 
(RGP) and lymphography, in some patients.Intravenous urography is mostly 
normal, hence its routine use is questionable. It may rarely demonstrate 
dilated para-calyceal lymphatics particularly when ureteric pressure is 
applied. 
Renal size may appear larger in severe lymphatic disease. It has poor 
sensitivity and often proves to be a costwaste. It is recommended if higher 
concentration of (Ag No3) is being planned for instillation.
Cystourethroscopy and retrograde pyelography
Cystourethroscopy (CPE) is very useful and often shows milky efflux from 
one or both ureteric orifices. 
Rarely, chylous efflux may be seen from bladder or even posterior urethra. 
Particularly when irrigant flow is stopped and bladder in semi-filled. In mild 
chyluria, ureteric catherization and split urinalysis for chyle may be done.62, 
Retrograde pyelography with fluoroscopic control and spot films often 
demonstrates pyelolymphatic backflow. Earlier studies demonstrated this in 
most of the cases and believed it to be diagnostic of chyluria. Later studies 
revealed that it is not specific of chyluria and may be seen in normal kidneys 
particularly if contrast is injected under pressure. However, it is more likely 
to occur in chyluria and should be differentiated from pyelovenous reflux, 
which is rather rare.(66) 
Lymphography
Lymphography shows lymphaticourinary fistulae. Numerous torurous 
dilated lymphatics around hilar region (lymphangiectasia) communicating 
with paravertebral lymphatics and contrast outling major/minor calyx. 
Contrast may enter pelvicalyceal system in 40% and may be followed into 
bladder.(67.68.69,70)Other associated findings may be; thoracic duct 
sometimes shows tortuosity and beading though mostly it is normal, round 
granular enlarged, nodes in para-aortic area, skipping of lymphatic chain in 
advance cases, dilated cisterna chylii may be demonstrated, abnormal 
lymphatics may be seen coursing down along line of ureter and transit of 
contrast medium from feet to thoracic duct is characteristically accelerated. 
Presently it is not recommended for routine use.
Lymphoscintigraphy
Recently, Radio-nuctide lymphoscintigraphy has been used to outline 
lymphatics in patients with various lymphatic disorders. (71, 72)A 
comparison is presented between the results of lymphangiography and 
lymphoscintigraphy in patients with chyluria  and these are correlated well. 
Lymphoscintigraphy being less invasive has been promulgated as 
investigation of choice but is not available at all centers. A simple diagnosis-
making algorithm is presented.
Elisa test for filariasis (fila test)
The ELISA test for filariasis is based on humoral immune response of the 
host to filarial antigen. The filarial ES antigen, immobilized on membrane is 
allowed to react with patients serum, followed by incubation with anti IgG 
enzyme conjugate. The presence of antibody is detected using a color 
change indicator system.(73) The specificity and sensitivity of this test has 
been reported to be 85 and 95%, respectively (Lymphatic filariasis fourth 
report of WHO expert committee of filariasis, 1984).
Renal biopsy
It is rarely done and mainly for research purpose. Light microscopic changes 
reported are; membranous nephropathy, mesangioproliferative nephropathy, 
endothelial cell proliferation; mild mononuclear cell interstitial infiltration. 
Ultrastructural changes reported are; immune complex type 
glomerulonephritis has been demonstrated in animal model, and also in 
human subjects. (74) How far these changes affect course of chyluria is not 
know because they are just the result of filariasis not of chyluria perse. 
Slight increase in renal size has also been reported in chyluria (? due to 
lymphatic obstruction).
Cloudy urine may be due to phosphates (and occasionally due to carbonates) 
precipitating  in alkaline urine. The phosphates and carbonates redisolve when acetic 
acid is added. Uric acid and urates cause a white, pink or orange 
cloud in acidic urine and redissolve on warming to 60 degree. Ammonium urate occurs 
in neutral and alkaline urine and dissolve in acetic acid..
Leucocytes may form a white cloud similar to that caused by phosphates but in this case 
the cloud remains after the addition of dilute ascetic acid. The presence of leukocytes is 
confirmed by microscopic examination of the urine.
                   TREATMENT OF CHYLURIA
MEDICAL TREATMENT
The medical treatment of chyluria falls into three categories:-
1. Dietary restriction of fats.
2. Substitution of fat with medium-chain triglycerides and 
3. Diethy carbazine for active filarial chyluria.
In the majority of patients Diethyicarbazine is capable of arresting mildly to
 moderatively active filarial chyiuria. The dosage used is 0.5 mg to 2 mg/kg 
three times  daily  for 1-3  weeks in some patients repeated courses of 
therapy are indicated. Because of secondary bacterial infections antibiotics 
have also proved helpful. Diethylcarbazine is only effective when active 
filarial disease is present. Once chyluriais is established   Diethyicarbazine  
is of limited value. With non parasitic chyiuria dietary alteration is the only 
non- surgical therapy available. 
This consists of reducing to the beneficial effect of 
Medium- chain Triglyceride substitution. However, this effect is not 
universally accepted. Bed rest and the use of a tight-corset to raise intra 
abdominal pressure have  been reported as successful in some Patients.
SURGICAL TREATMENT
The surgical options can be divided into six categories
1. Renal pelvic instillation sclerotherapy (RPIS) is a minimally invasive 
    treatment modality in treatment of chyluria. 
2.  Renal Hilar Lymphatic stripping – open surgical.and laparoscopic 
3.  Hilar stripping coupled with renal decapsulation
4.  Internal drainage by surgical means, and 
5. Autotransplantation or nephrectomy
1. Renal pelvic instillation sclerotherapy (RPIS)
The various agents used as sclerosants are as follows: 
1. silver nitrate 
2. povidone iodine,
3. Sodium iodide,
4. Potassium bromide,
5. Dextrose (50%)
6.  Urograffin76%,
7. Hypertonic saline (3%),
8. combination therapy.
Indications for sclerotherapy
Failure of conservative management-DEC therapy and dietary modifications.
Mechanism of action of the sclerosant
Injected sclerosant reaches lymphatics through the pyelolymphatic fistula 
where it induces an inflammatory reaction in the lymphatics. This leads to 
chemical lymphangitis and oedema of the lymphatic channels. Finally, 
healing occurs by fibrosis causing blockade of the offending lymphatics and 
communicating lymphatic fistula.
1. LAVAGE OF RENAL PELVIS WITH SILVER NITRATE
YAMAUCHI stated that silver nitrate was an effective therapeutic agent for 
chyluria. Of 888 cases of renal pelvic instillations. Therapy throughout 
JAPAN from1957 to 1961 silver nitrate solution was used in 585 965.8%) 
and better results were obtained than  with the use of  contrast medium or 
saline. The purpose of renal pelvic instillation.Therapy is to cauterize and  
obstruct the fistulas between the renal calices or  pelvis and the 
renal lymphatics. When chyluria is severe with fibrin clots, therapy is 
done while the patient is placed on a fat  restricted diet. Treatment is 
initiated with  0.1%silver nitrate to encourage patient tolerance to the 
therapy which causes backache  and pain.The final concertration of  
silver nitrate is limited to 0.5%.Treatment is performed  in the outpatient 
clinic using local  anaesthesia. Chyluria stopped with instillation therapy in 
almost 60% of the patients recurred in half of 45 patients followed for > 2 
years (16 on the ipsilateral side). The results of renal pelvic instillation 
therapy in 217 patients between 1952 and 1973 were as follows:-  Chyluria 
stopped in 129 patients (59.4%) .Of 45 Patients followed for < 2 years 
relapse occurred on the ipsilateral side in 16 and from an undetermined side 
in7. Lavage of the renal pelvis using a  sclerosing solution of 1% to 3%  
silver nitrate or 10% to  15% potassium lodide (if the kidney was the source 
of chyluria) has been used for many   Years. (23)Endoscopic sclerotherapy 
with 1% silver nitrate has been associated with serious complications like
 acute renal failure, papillary necrosis, massive hematuria and even death.
LAVAGE OF RENAL PELVIS WITH BETADINE
In 1998, Shanmugam et al. described 0.2% povidone iodine 
instillation as safe and effective in curing chyluria.(10) 
Bhat et al treated 20 patients with the same technique (51) (2ml of 
povidone iodine + 8 ml of distilled water a total of 10 ml).
Instillation of povidone iodine initially results in inflammatory edema 
and blockage of the lymphatics. Later, inflammatory fibrosis leads to 
permanent obstruction of the lymphatic channels and cure of chyluria. 
Povidone iodine is iodine complexed with the non ionic surfactant 
polymer polyvinyl pyrrolidone and has a local sclerosant action. As a 
sclerosant it has been used in the management of renal cyst (59) and 
lymphocele following renal transplanation(60) . However, it may be 
associated with serious iodine hypersensitivity reactions. Other 
agents that have been tried are 50% glucose, normal saline,10-25% 
sodium iodide and 15% potassium iodide. The reported success rate 
varies from 59-68% with recurrence rate of 51%(61).
The recurrence rate with this dose is high and there is no
major study regarding the effective dose and the long term results. So 
we planned this study.
Combination therapy
It consists of mixture of two sclerosants in a hope to get a better and stronger 
fibrotic response. Nandy et al. used combination therapy for the renal pelvic 
instillation where they combined povidone iodine with 50% dextrose. They 
showed a response rate of 87% with a recurrence rate of 13% in their study 
of 46 patients which were followed up for 24 months.(78) 
2. Renal Hilar lymphatic stripping
The surgical technique of stripping and interruption of the renal pedicle 
lymphatics was  first  reported by KATAMINE IN JAPAN in 1952. 
OKAMOTO AND associates reported the results of the operation in 70 
cases. Reports presented from outside Japan include those of  TORRES and 
ESTRADA, CALLAHAN and associates,YU and  associates and  22).
The purpose of the operation is to isolate the affected kidney and upper ureter from 
adjacent issues, and ligate and disconnect the renal pedicle lymphatics that accompany 
the renal pedicle lymphatics that accompany the renal vessels and ultimately link the 
cisterna chyli and the kidney. The operation interrupts renal lymphactics , preventing 
chylous lymph backflow 
to the kidneu chyluria ceased immediately postoperatively in 98% of the patients so 
treated. Follow up studies indicated persistent excellent results. The reason for 
ipsillateral recurrence may be recanalisation of lymphatics but this occurred in only 6.2 
% of the patients who were followed. Meticulous care should be taken not leave even 
the small lymphatics around  the renal arteries uninterrupted ligation of the lymphatic 
with skill is also essential to discourage recanalisation.Chyluria developing  in the 
opposite renal pedicle lymphatics, causing a reflux into the un operated kidney, 
contralateral chyluria  occurred in8.1% of the followed patients.  Operation is of benefit 
not only to relieve Dysuria owing to fibrin clots but also to 
obviate dietary restrictions serum protein levels returned to normal postoperatively.
Callahan and associates injected Methylene blue into some of thelarge visible 
lymphatics during operation so that they can be seen and stripped away.Karanjavala 
adopted a new surgical technique of lymphatic Disconnection. Half on hour before the 
operation, the lympahatics were cannulaed on the dorsum of the foot, which was 
continued through out the operation. The lymphatic varies in the affected area was well 
demon started. 
The kidney was approached through a standard renal incision, including resection of the 
12th rib.Lymphatic tributaries around the renal vein artery are seem coming from the 
main lymphatic trunk near the venacave .These are  severed and ligated. For the lower 
ureterand bladderlymphatic disconnection the oblique muscle-cutting exraperitoneal 
approach is adequate.
Laproscopic chylolymphatic disconnection 
Chylolymphatic disconnection can be done by both open surgical technique 
and laparoscopy.(47) Cases have been reported via transperitoneal and 
extraperitoneal access.(46, 47, 48.49) 
The success rate of open surgical technique has been reported up to 98% at 
follow up of 1 year.50 Laparoscopy in spite of being minimally ivasive has
 all the advantages of open surgery. Several authors have reported equally 
comparable results after laparoscopic chylolymphatic disconnection. 
(47, 48, 49)  The advantages of retroperitoneoscopic chylolymphatic 
disconnection are; easy and straight access to the kidney, besides the other 
advantages of laparoscopy like magnified view for better identification of 
lymphatics, minimal morbidity, shorter hospital stay and lesser time off.
3 & 4. HILAR lymphatic stripping couples with renal decapsulation and 
NEPHRECTOMY
5. Autotransplantation or nephrectomy
Brunkwall et a 52 reported a case of recurrent chyluria after failed initial surgical 
treatment, which consisted of stripping of the renal pedicle. Patient was successfully 
managed by renal autotransplantation. Before the advent of 
sclerotherapy and chylolymphatic disconnection more formidable procedure like 
nephrectomy has also been described for recurrent chyluria. 
Yamauchi has stated that nephrectomy, capsulectomy and the removal of perirenal 
lymph channels and a few regional nodes probably have no place in treatment of 
chyluria. Since dilated lymphatics were not seen in the peripheral area, this accounted 
for the failure of the operation of decapsulation.
IV. INTERNAL DRAINAGE BY SURGICAL MEANS
Dr. Cockettand Goodwin have advocated a shunt between a single varicose lymphatic 
and the testicular or ovarian vein for the relief of lymphatic 
hyoertension. A frequently reported cause for recurrence of chyluria, after renal hilar 
stripping, result from failure to fully ligate or disconnect all 
lymphatic channels. With an internal drainage procedure, the effect of incomplete 
stripping in minimized. Anastomosis of the lumbar lymphatic vessel to the spermatic 
vein is a technically difficult procedure. The anastomosis is performed with loupe 
magnification. 
Today a higher anastomotic  patency rate is possible, with the 
use of an operating microscope to anastomose a lymphatic vessel with a venous tributary 
of similar size. 
Lympho-venous anastomosis
This is the most physiological method of surgical correction for recurrent chyluria.
(55.56,57,58) The procedure increases the drainage of lymph into venous system, which 
rapidly decreases the intralymphatic pressure. Thus facilitating the healing of pyelo-
lymphatic fistulae. The procedure is technically cumbersome as lymphatics are difficult 
to identify, lymphatic channels are thin, brittle and liable to collapse, which requires 
microsurgical expertise.
Retro-peritoneal lympho-venous anastomosis
The technique was described by Cockett and Goodwin.(58) Jiang and Hu (1982) treated 
29 patients of chyluria with retroperitoneal lympho-venous 
anastomosis (RPLVA). At a follow-up of 1-14 years, 24 patients were cured and four 
were improved. The shortcomings of RPLVA are deep seated operative field, risk of 
renal pedicle injury, risk of renal artery stenosis and 
renovascular hypertension. (58) 
Trans-inguinal spermatic lympho-venous anastomosis
The procedure has been described in male patients with recurrent chyluria. Inguinal 
hernia incision is used. (57,58). About 1 ml of 1% methylene blue + 1% procaine 
injected in testis. Three large blue stained lymphatics and spermatic veins (of similar 
caliber) are dissected out. End-to-end interrupted anastomosis is done by 10-0 nylon. Xu 
et al. (55) described 64 patients in whom transinguinal spermatic lymphangiovenous 
anastomosis was performed. Follow up was 6 months to 11 years in 50 of the patients. 
Chyluria disappeared completely in 30 (60%). In another study by Zhao et al. (57) 
reported a success rate of 76.3%. The procedure has the advantage of a superficial 
operative field and is simple and less traumatic. 
Inguinal lymph node-saphenous vein anastomosis
Here, a lymphnodo-venous anastomoses is made according to the principles of 
lymphovenous shunt. A conical tissue of lymph node close to the greater 
saphenous vein in the inguinal region is removed and the remaining tunnel-shaped node 
is anastomosed to the vein to drain the lymph into the venous system. Hou et al (53) 
treated 30 cases of chyluria and 21 cases were followed up for 6 months after the 
operation. Among them, 16 (76.2%) showed disappearance of chyluria and 2 (9.5%) 
were improved, giving an effective rate of 85.7%. The operation avoids damage to both 
the afferent and efferent lymphatic vessels and affords a large anastomotic stoma for free 
passage of the lymph into the vein. In another study by Ji et al (54) where in males a 
lymphatico-venous anastomosis of the spermatic cord was performed and in females the 
lower inguinal lymph nodes were anastomosed to the branches of the greater saphenous 
vein. In patients with scrotal lymphangial fistulae, bilateral lymphatico-venous 
anastomosis was carried out after excision of the fistula and scrotoplasty. Thirty-seven 
patients were followed up for 1-9 years, 36 being cured by a single operation. 
           AIM AND OBJECTIVE 
1. To determine the percentage of Povidone Iodine 
required for cure of chyluria after single dose  renal 
pelvis instillation. 
2. To compare efficacy of percentage of Povidone 
                      
                   Iodine versus side effects
           Materials and Methods
Between September 2004 and April 2007, all patients who presented 
with complaints of milky  white colored  urine (chylous) were evaluated.
Patients were asked to bring freshly voided urine in a transparent 
bottle. After inspection Ether test was done to demonstrate chyluria.
Ether test
5cc of ether is added to 5 cc of urine added to see the solubility.
Urine - albumin
- Sugar
 - Deposits
Urine culture and sensitivity
Blood –   TC
             -  DC
- ESR
Blood smear for microfilaria
Blood urea
Sr.Creatinine
Blood sugar – fasting
         - Post prandial
Ultrasound KUB
X ray KUB.
IVU done in selected cases who presented with 
1. Haematuria
2. haemetochyluria. 
3. Ultrasongram showing subtle changes in the kidney
4. Episodes of febrile illness
Dietary advice
To avoid saturated fatty acids fatty diet - avoiding ghee,butter,ground 
nut oil.Advised to take sunflower oil.
Medical treatment
Diethylcarbazine (6 mg/kg Body weight) for - 3 weeks.
restriction of strenuous activity. 
If urine culture was positive they were treated according to the 
sensitive drugs before povidone iodine instillation.
The concentration of povidone iodine used 
Group I - 0.5 %  - 18 Patients
Group II - 1   %  - 18 Patients
Group III - 2.5 %  - 18 Patients
Group IV - 5     %  - 18 Patients
The commercially available form povidone iodine is 5 % 
It is diluted with distilled water to get the required concentration. 
For each patient povidone iodine from a newly opened bottle was 
used.Patients were selected according to registration in the order of 
.5, 1, 2.5, 5 % concentration.
Procedure
On the day of procedure Patients were advised to take butter 25 gms 
with bread and if non vegetarian  2 boiled eggs 2-3-hours prior 
to cystoscopy. They were asked to collect urine and show it to us just 
before putting the patient on  table. If the urine is clear then the 
procedure is postponed. If the urine is chylous  Injection Cefataxime 1 
gram is given IV after test dose.
Under local anasthesia with 20 F cystoscope withg 30 degree 
telescope was done with Normal saline for irrigation. The side of 
efflux was noted carefully. If reflux was found on both sides then right 
side is selected for treatment and the left  side instillation after a 
period of 3 weeks with the same dose.
A 5 F ureteric catheter was passed into the selected ureter and 
Positioned in the pelvis.  5 - 7 ml of selected prepared concentration 
of  povidone iodine  was instilled into the renal pelvis slowly over a 
period of 1 to 2 minutes.  During the procedure any pain or other 
reaction was noted. Patients were observed for 24hours and 
discharged the next day.
At the time of discharge the following were noted
1. Fever
2. Loin pain
3. Haematuria. 
4. Urine sample for culture. 
At the time of discharge Tab Gatiflox 1 od was given for 5 days and 
Tab. Drotavarine sos.
All patients were reviewed after 3 weeks and if still symptomatic and 
the urine chyle is positive then the same procedure was  repeated 
with the  next higher concentration of povidone iodine on the same 
side in unilateral cases and in bilateral cases on both sides in 2 
sittings with a time interval of 3 weeks.
The maximum concentration used was 5 % and if there was 
no response  then povidone iodine double wash was given i.e. 5 % 
given as usual followed by another wash after a time interval of 6 to 8 
hours.If still not responding then we group them as refractory.
All the cases were reviewed at 1, 3, 6 and 12 months.
         OBSERVATION 
A Total of 72 patients were included in this study, of these the maximum incidence of 
chyluria occurs between the third and fourth decade.
1 patient  - less than 20 years 
13 patients - 20 to 30 years 
25 patients - 30 to 40 years 
15 patients - 40 to 50 years 
12 patients - 50 to 60 years 
6 patients - 60 to 70 years.
Of the total 72 patients
Females - 44 / 72 patients (61.11 %) 
Male - 28 / 72 patients (38.88 %).
The sex incidence ratio was almost 1.6: 1.
The duration of complaints of passing milky urine varied from 1 month 
to 20 years and most of the patients had symptom free interval in 
between.
Haematochyluria was present in 8 patients and history of passing chylous clots was 
found in 11 parents. Obstructive voiding symptoms were found in 3 cases. Acute urinary 
retention was found in 3 cases.
Of the 28 male patients 2 has bilateral hydrocele and none of the 72 patient had filarial 
limbs.  
Ultrasound KUB showed normal upper tracts in all the cases and in 4 cases 
chylous balls were demonstrated in the bladder.
Intravenous urogram was normal in all (7 cases) in whom it was done.
Cystoscopy findings  
chylous efflux On the right side  - 27 cases 
chylous efflux on the left side -  23 cases 
chylous efflux bilateral -  22 cases. 
Urine Culture- positive 
Total - 7 cases
E.Coli  - 5 cases
proteus - 1 case 
klebsiella - 1 case 
Renal function was normal in all patients. 
Of the 72 patients 2 were diabetic and after povidone iodine instillation there 
was no significant side effects.
Disappearance of chyle after 3 weeks of Povidone Iodine instillation was noted as 
success.Appearance of chyle at any time during the study period was considered as 
failure was noted as success.
Group I 
Povidne iodine concentration - 0.5 %  
Total number of cases - 18 cases 
Success - 13 cases 
Failure - 5 cases 
Percentage of success - 72.22 %  
Complications  immediate - nil
Late - nil
Group II 
Povidne iodine concentration - 1 %  
Total number of cases - 18 cases 
Success - 7 cases 
Failure - 11 cases 
Percentage of success - 33.33 %  
Complications  immediate - nil
Late - nil
Group III 
Povidone iodine concentration - 2.5 %  
Total number of cases - 18 cases 
Success - 15 cases 
Failure - 3 cases 
Percentage of success - 83.33 %  
Complications  immediate - nil
Late - nil
Group IV 
Povidne iodine concentration - 5 %  
Total number of cases - 18 cases 
Success - 17 cases 
Failure - 1 case 
Percentage of success - 94.44 %  
Complications  immediate - severe pain (38.8 %)
Late - nil
Of the 20 failures 8 cases had 
bilateral reflux and 12 had unilateral reflux. 
Failure was not influenced significantly by unilateral or bilateral reflux.
In our study of 72 cases no patient developed anaphylaxis following 
povidone iodine instillation. 
In our study 2.5 % concentration of povidone iodine has more success rate (83.33 %) 
with no significant side effects.
Age distribution
Cystoscopy - Chyle efflux
DISCUSSION
Yamauchi (11) has reported the usual occurrence of chyluria between the second and 
fifth decade of life. In our study out of 72 patients 54 were in between the second and 
fifth decade of life. (75 %).
According to Torres and associates, no sex predominance exists (42). 
In our study out of the 72 patients 44   were females and 28 were male.
The sex incidence ratio was 1.6: 1.
The duration of symptoms ranged from 2 month to 20 years.
Most of them had symptom free interval in between. The symptom free interval varies 
from months to years.
Shanmugam used single instillation of .2 % povidone iodine in five patients 
and there was no recurrence in 6 months follow up. (10)
Singh had studied two-types of dosage schedule in chyluria patients. In 
the first protocol, 8 h instillation of the povidone iodine was done for 3 days 
(total of nine doses) while in the second protocol weekly instillation of the 
povidone iodine was done for 6 weeks. The total number of patients 
included in the study was 27 in first protocol and 25 in the second protocol. 
At median follow-up of 32 months in 8 h instillations group there was 85% 
response rate with mean disease free duration  of 27 months. While in 
weekly instillation group a response rate of 75% with disease free duration  
of 22 months were observed. (88)
Shailendra conducted a randomized prospective and comparative study to 
evaluate the efficacy and toxicity of 1% silver nitrate, 0.2% povidone iodine 
and 50% dextrose as RPIS for treating chyluria.
 The dextrose treatment was discontinued at mid-term because of poor 
success. Of 85 patients, 44 received silver nitrate and 41 povidone iodine; 
both groups were well-matched and the mean follow-up was 28.4 and 
23.3 months, respectively. 'Immediate clearance' was recorded in 91% and 
98%, and recurrence in 21% and 22% of patients after the first course of 
RPIS, after silver nitrate and povidone, respectively; Kaplan-Meier estimates 
of 'disease-free duration' in the two groups (23.6 vs 20.1 months) were also 
similar (P = 0.7906). The cumulative success rate after two courses of RPIS 
was 82% (silver nitrate) and 83% (povidone; P = 1.0). Five (11%) patients 
in the silver nitrate and one (2%) in the povidone group had significant flank 
pain during treatment. He concluded that Povidone iodine 0.2% is as 
effective for RPIS as 1% silver nitrate.
In our study 5 % Povidne iodine concentration (Group IV) had a 
Success rate of 94.44 % with severe pain as immediate  
Complication (38.8 %). with a recurrence rate of 5.6 %.
With   2.5 % Povidone iodine concentration (Group III) the Success
 rate was - 83.33 %  with recurrence 16.67.
The manifestation of chyluria depends upon the site of involvement 
and the anastomotic variation of lymphatic system in the individual 
patient. The anastomotic variation primarily occurs at the cisterna 
chyli where the lumbar trunks and the intestinal trunks join. The 
classical cisterna chylii is seen in only about 47% of normal 
individuals, and the intestinal trunk in such cases drains in 
the lumbar trunks of one side or directly in the thoracic duct either as 
a single trunk or as multiple smaller ones. This may explain the 
presence of unilateral chylous oedema of only one extremity or 
unilateral chyluria. The unilateral findings are more common on the 
left side.(76,77) 
In our study   of the 72 cases chylous efflux on the right side was for  
27 cases and for the left side   23 cases and bilateral efflux in 22 
cases with a ratio of the ratio Right : left -  1.17 : 1 with a slight shift to 
right side.
          SUMMARY AND CONCLUSION
Between September 2004 and April 2007 all patients of chyluria were studied 
with single dose renal pelvis instillation of Povidone Idine 
5 % Povidone Idine had the best success rate in clearing chyluria (94.4 %).
The most common complication was severe pain which occurred in 
38.8 %)
2.5 % Povidone Idine had a success rate of 83.33 % with no significant 
during and after the procedure.
1 % Povidone Idine had the most failure. The success rate was 33.33 %. 
which was worse than .5 % Povidone Idine. There was no significant 
complication.we cannot come to a conclusion why this variation happened.  
.5 % Povidone Idine had a the sucess rate of 72.2 % with no significant 
complicating
We conclude that 2.5 % Povidone Iodine single pelvis instillation is the ideal dose, 
which gives good success with no major complications                                     
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Consent form
I am ________________________ willing to participate in the study titled “The Effect 
of 
Levofloxacin in Paucibacillary Leprosy”. I am aware that I will be given a new drug, 
Levofloxacin instead of Ofloxacin in the ROM regimen for the treatment of the leprosy 
lesion which I am suffering from. The purpose and the advantage of the study has been 
explained in the mother tongue by the investigator. I am also aware that I can 
discontinue 
from the study whenever I wished to do so.
Date;
Place;                                                        Signature of the Patient/Guardian
age group
10 – 20 1
20 – 30 13
30 – 40 25
40 – 50 15
50 – 60 12
60 – 70 4
70 – 80 2
Tuberculoid Leprosy (TT):
Proforma- chyluria
Name
Age    sex 
Address
Complaints:     duration
LUTS
Henatochyluria
Ureteric colic
AUR
H/O previous treatment
Examination: genitalia
Lower limb
Urine - albumin
- Sugar
 - Deposits
Urine culture and sensitivity
Blood –   TC
             -  DC
• ESR
Blood smear for microfilaria
Blood urea
Sr.Creatinine
X-ray KUB
USG- KUB:
Cystoscopy:
Treatment:betadine wash Side 
% of betadine used
Complications: immediate
                         Late
Follow up; USG KUB;
Immediate
1 month
3 month;
6 month;
1 year:
Miscellaneous  :


